<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Gonococcal infection in the newborn
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Gonococcal infection in the newborn
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Gonococcal infection in the newborn
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael E Speer, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen M Puopolo, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 06, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perinatal acquisition of sexually transmitted infections can have serious consequences for the newborn. Ophthalmia neonatorum (newborn conjunctivitis) was caused principally by
         <em>
          Neisseria gonorrhoeae
         </em>
         at one time in the United States and was the most common cause of blindness. Although this newborn infection has decreased considerably throughout the world with the advent of routine newborn ophthalmologic prophylaxis, the consequences of untreated disease remain grave.
        </p>
        <p>
         Gonococcal infection in the newborn is reviewed here. The epidemiology and pathogenesis of
         <em>
          N. gonorrhoeae
         </em>
         infection are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7587.html" rel="external">
          "Epidemiology and pathogenesis of
          <i>
           Neisseria gonorrhoeae
          </i>
          infection"
         </a>
         .)
        </p>
        <p>
         Neonatal infection with other sexually transmitted organisms is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">
          "Chlamydia trachomatis infections in the newborn"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15400.html" rel="external">
          "Congenital syphilis: Management and outcome"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6037.html" rel="external">
          "Neonatal herpes simplex virus infection: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6040.html" rel="external">
          "Neonatal herpes simplex virus infection: Management and prevention"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4958.html" rel="external">
          "Hepatitis viruses and the newborn: Clinical manifestations and treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6006.html" rel="external">
          "Diagnostic testing for HIV infection in infants and children younger than 18 months"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H93602276">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of neonatal gonococcal infection relates to the prevalence of infection among women of childbearing age, which varies somewhat worldwide. In high-income countries, the prevalence of gonococcal infection among pregnant women is &lt;1 percent; the prevalence in low- and middle-income countries is considerably higher. (See
         <a class="medical medical_review" href="/z/d/html/7587.html" rel="external">
          "Epidemiology and pathogenesis of
          <i>
           Neisseria gonorrhoeae
          </i>
          infection", section on 'Global incidence'
         </a>
         .)
        </p>
        <p>
         In pregnant women, coinfection with
         <em>
          Chlamydia trachomatis
         </em>
         is common and HIV transmission is heightened in the presence of gonorrhea [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/89490.html" rel="external">
          "Epidemiology of
          <i>
           Chlamydia trachomatis
          </i>
          infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7587.html" rel="external">
          "Epidemiology and pathogenesis of
          <i>
           Neisseria gonorrhoeae
          </i>
          infection", section on 'Association with HIV'
         </a>
         .)
        </p>
        <p>
         In the newborn, the eye is the most frequent site of gonococcal infection [
         <a href="#rid3">
          3
         </a>
         ]. (See
         <a class="local">
          'Ophthalmia neonatorum'
         </a>
         below.)
        </p>
        <p>
         The epidemiology of
         <em>
          N. gonorrhoeae
         </em>
         infection is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7587.html" rel="external">
          "Epidemiology and pathogenesis of
          <i>
           Neisseria gonorrhoeae
          </i>
          infection", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Perinatal transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         Newborns typically acquire gonococcal infection during delivery. Perinatal transmission occurs in 30 to 40 percent of cases of maternal cervical infection in the United States [
         <a href="#rid4">
          4
         </a>
         ]. Intrauterine infection also can occur after rupture of the membranes.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Association with prematurity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maternal gonococcal infection during pregnancy is associated with increased risk of preterm delivery [
         <a href="#rid5">
          5-13
         </a>
         ]. In a population-based study from the United States (2016 to 2019), rates of preterm birth among pregnancies with and without maternal gonorrhea were 12 versus 8 percent, respectively (adjusted odds ratio 1.11; 95% CI 1.08-1.15) [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">
          "Spontaneous preterm birth: Overview of risk factors and prognosis", section on 'Infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          OPHTHALMIA NEONATORUM
         </span>
         <span class="headingEndMark">
          —
         </span>
         The eye is the most frequent site of gonococcal infection in the newborn.
        </p>
        <p class="headingAnchor" id="H1946338974">
         <span class="h2">
          Epidemiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          N. gonorrhoeae
         </em>
         is a rare cause of neonatal conjunctivitis in areas of the world where ophthalmologic prophylaxis is routine [
         <a href="#rid14">
          14
         </a>
         ]. In one series of 332 neonates with conjunctivitis, one-half had no pathogen detected. The most common bacterial pathogens were
         <em>
          H. influenzae
         </em>
         (17 percent),
         <em>
          S. pneumoniae
         </em>
         (12 percent),
         <em>
          S. aureus
         </em>
         (9 percent), and
         <em>
          C. trachomatis
         </em>
         (8 percent); no cases of gonococcal infection were identified [
         <a href="#rid15">
          15
         </a>
         ]. In other series,
         <em>
          S. aureus
         </em>
         was the most common pathogen and
         <em>
          N. gonorrhoeae
         </em>
         and
         <em>
          C. trachomatis
         </em>
         were responsible for &lt;5 percent of cases [
         <a href="#rid16">
          16,17
         </a>
         ]. In a report from the United States Centers for Disease Control and Prevention (CDC), the estimated incidence of gonococcal conjunctivitis from 2010 through 2015 was 0.2 cases per 100,000 live births [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection typically causes a purulent conjunctivitis, with profuse exudate and swelling of the eyelids (
         <a class="graphic graphic_picture graphicRef66751" href="/z/d/graphic/66751.html" rel="external">
          picture 1
         </a>
         ). Without treatment, the infection can extend from the superficial epithelial layers into the subconjunctival connective tissue and the cornea, leading to ulceration, scarring, and visual impairment.
        </p>
        <p>
         The infection usually becomes manifest two to five days after birth. However, factors including ophthalmic prophylaxis, inoculum size, or variations in virulence may result in a more indolent course and delay in onset.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ophthalmia neonatorum is confirmed by microbiologic testing of the exudate. Neonates who develop conjunctivitis after the first day of age or appear to have severe or persistent chemical conjunctivitis should be evaluated.
        </p>
        <p>
         In general, nucleic acid amplification testing (NAAT) is the test of choice for the initial microbiologic diagnosis of
         <em>
          N. gonorrhoeae
         </em>
         infection, although culture remains an important diagnostic tool. A positive Gram stain of the conjunctival exudate showing typical gram-negative intracellular kidney bean-shaped diplococci is supportive but not diagnostic. Caution should be used in interpreting the Gram stain results since other nonpathogenic
         <em>
          Neisseria
         </em>
         species can be mistaken for
         <em>
          N. gonorrhoeae
         </em>
         [
         <a href="#rid1">
          1
         </a>
         ]. Culture of the exudate should be performed using selective media (eg, modified Thayer-Martin medium) that inhibit normal flora and nonpathogenic
         <em>
          Neisseria
         </em>
         organisms. Testing other sites (eg, oropharyngeal and rectal swabs) can also be helpful in confirming the diagnosis.
        </p>
        <p class="headingAnchor" id="H2197722419">
         <span class="h2">
          Additional evaluation
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation for coinfection and/or other causes
         </strong>
         – Newborns with conjunctivitis should be evaluated for
         <em>
          C. trachomatis
         </em>
         using NAAT. Coinfection with this organism is common with gonococcal disease. (See
         <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">
          "Chlamydia trachomatis infections in the newborn"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition to testing for
         <em>
          N. gonorrhoeae
         </em>
         and
         <em>
          C. trachomatis
         </em>
         , newborns with purulent conjunctivitis should have a bacterial culture performed on the exudate to evaluate for other bacterial causes. In some cases, viral testing (eg, for herpes simplex virus) may also be warranted. (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation of the mother
         </strong>
         – The infant's mother and the mother’s sexual partner(s) should be evaluated and treated for gonococcal infection. (See
         <a class="medical medical_review" href="/z/d/html/15892.html" rel="external">
          "Treatment of uncomplicated gonorrhea (
          <i>
           Neisseria gonorrhoeae
          </i>
          infection) in adults and adolescents"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The mother also should be evaluated for other sexually transmitted infections, including HIV infection. (See
         <a class="medical medical_review" href="/z/d/html/7596.html" rel="external">
          "Screening for sexually transmitted infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H606237247">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other causes of purulent conjunctivitis in newborns include other bacteria (eg,
         <em>
          Staphylococcus aureus,
         </em>
         <em>
          Haemophilus influenzae, Streptococcus pneumoniae
         </em>
         ,
         <em>
          C. trachomatis
         </em>
         ) and viral infections (eg, adenovirus, herpes simplex virus). As previously discussed,
         <em>
          S. aureus
         </em>
         ,
         <em>
          H. influenzae
         </em>
         , and
         <em>
          S. pneumoniae
         </em>
         are considerably more common causes of purulent conjunctivitis in newborns in areas of the world where ophthalmologic prophylaxis is routine. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
         Noninfectious causes of neonatal conjunctivitis include chemical conjunctivitis (caused by prophylactic eye drops or ointment) and dacryostenosis. However, these causes typically are not associated with purulent eye discharge. (See
         <a class="medical medical_review" href="/z/d/html/6274.html" rel="external">
          "Congenital nasolacrimal duct obstruction (dacryostenosis) and dacryocystocele"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6907.html" rel="external">
          "Conjunctivitis"
         </a>
         .)
        </p>
        <p>
         The timing of onset and clinical findings can help distinguish
         <em>
          N. gonorrhoeae
         </em>
         from other causes of neonatal conjunctivitis.
         <em>
          N. gonorrhoeae
         </em>
         infection typically presents two to five days after birth and is characterized by profuse exudate and swelling of the eyelids (
         <a class="graphic graphic_picture graphicRef66751" href="/z/d/graphic/66751.html" rel="external">
          picture 1
         </a>
         ). However, microbiologic tests (NAAT, Gram stain, and culture) are necessary to confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of neonat
         <em>
          al N. gonorrhoeae
         </em>
         conjunctivitis consists of a
         <strong>
          single dose
         </strong>
         of
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         (25 to 50 mg/kg [maximum dose 250 mg] given intravenously [IV] or intramuscularly [IM]) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          Ceftriaxone
         </a>
         should
         <strong>
          not
         </strong>
         be used in neonates receiving calcium-containing IV fluids, including parenteral nutrition, since this can cause precipitation leading to severe reactions [
         <a href="#rid18">
          18,19
         </a>
         ]. In addition, we avoid use of ceftriaxone in preterm neonates and newborns with clinically significant hyperbilirubinemia since ceftriaxone displaces bilirubin from albumin and may increase the risk of neurotoxicity. While this usually is not a concern when giving only a single dose, we generally avoid ceftriaxone in neonates requiring treatment of hyperbilirubinemia. (See
         <a class="medical medical_review" href="/z/d/html/4994.html" rel="external">
          "Unconjugated hyperbilirubinemia in neonates: Risk factors, clinical manifestations, and neurologic complications", section on 'Risk factors for neurotoxicity'
         </a>
         .)
        </p>
        <p>
         Alternative agents that can be used in these circumstances include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          Cefotaxime
         </a>
         (if available) – Given as a single dose (100mg/kg) IV or IM
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          Ceftazidime
         </a>
         – Given as a single dose (50 mg/kg) IV or IM
        </p>
        <p>
        </p>
        <p>
         Topical antibiotic therapy alone is inadequate for treatment of gonococcal conjunctivitis [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         In addition to systemic antibiotic therapy, the eyes should be irrigated frequently with
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         until the discharge clears.
        </p>
        <p>
         Infants with gonococcal ophthalmic disease should be hospitalized and observed for response to therapy. If the infant develops evidence of disseminated infection or is deemed to be at high risk (eg, mother with no prenatal care, history of sexually transmitted infections, or substance abuse), additional evaluation should be performed (including blood and CSF cultures) and presumptive treatment for disseminated infection should be administered. (See
         <a class="local">
          'Disseminated infection and scalp abscess'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most effective measure to prevent both gonococcal and chlamydial infections is to diagnosis and treat these infections in pregnant women. In addition, prophylactic antibiotic eye therapy reduces the risk of gonococcal conjunctivitis; however, it is not effective in preventing
         <em>
          C. trachomatis
         </em>
         conjunctivitis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maternal screening
         </strong>
         – Screening for gonorrhea during pregnancy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/446.html" rel="external">
          "Prenatal care: Initial assessment", section on 'Gonorrhea'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal prophylaxis
         </strong>
         – The risk of contracting gonococcal conjunctivitis is markedly reduced by effective prophylaxis [
         <a href="#rid20">
          20,21
         </a>
         ]. Neonatal prophylaxis consists of
         <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">
          erythromycin
         </a>
         (0.5%) ophthalmic ointment applied to each eye in a single application at birth [
         <a href="#rid1">
          1,2,22
         </a>
         ]. This is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant", section on 'Eye care'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          OTHER LOCALIZED INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to conjunctivitis, localized infection of other mucosal surfaces can occur. The pharynx, vagina, urethra, and anus can be affected [
         <a href="#rid23">
          23
         </a>
         ]. Scalp abscesses may result from infection introduced by a fetal monitoring electrode [
         <a href="#rid24">
          24
         </a>
         ]. Neonates with a scalp abscess or in whom sepsis is suspected should be treated for disseminated infection. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         Diagnostic evaluation consists of cultures from the affected site, blood, and cerebrospinal fluid (CSF) to assess for disseminated infection.
        </p>
        <p>
         Most localized infections can be treated with a single dose of an extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available], or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) using the same dosing as for conjunctivitis. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
         The exception is gonococcal scalp abscess, which is treated in the same manner as disseminated infection. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          DISSEMINATED INFECTION AND SCALP ABSCESS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disseminated infection may present as sepsis, arthritis, or meningitis. Septic arthritis is the most common manifestation of disseminated infection [
         <a href="#rid25">
          25-27
         </a>
         ]. Gonococcal bacteremia and/or meningitis are rare in the newborn but can be a complication of ophthalmia neonatorum and other localized infections, particularly scalp abscess [
         <a href="#rid4">
          4,28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features vary depending on the type of infection:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sepsis – The signs and symptoms of neonatal sepsis are nonspecific. They are summarized in the table and are discussed in greater detail separately (
         <a class="graphic graphic_table graphicRef72985" href="/z/d/graphic/72985.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5043.html" rel="external">
          "Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meningitis – Common presenting signs and symptoms include fever, irritability, lethargy, apnea, seizures, vomiting, and poor feeding. The clinical features of neonatal meningitis are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6005.html" rel="external">
          "Bacterial meningitis in the neonate: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Arthritis – Gonococcal arthritis typically presents at 2 to 21 days of age. The infant may appear only mildly to moderately ill, and the temperature may be normal or slightly elevated [
         <a href="#rid27">
          27
         </a>
         ]. Multiple joints usually are affected. The infant typically refuses to move the painful, affected limb. (See
         <a class="medical medical_review" href="/z/d/html/6030.html" rel="external">
          "Bacterial arthritis: Clinical features and diagnosis in infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Scalp abscess – Infection can occur in infants who underwent fetal scalp electrode placement prior to delivery if the mother had an unknown or untreated infection [
         <a href="#rid24">
          24,29
         </a>
         ]. Necrosis and scalp abscess can occur, which is associated with a high risk of disseminated infection.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosis of disseminated infection is confirmed by a positive culture for
         <em>
          N. gonorrhoeae
         </em>
         from blood, cerebrospinal fluid (CSF), or synovial fluid. Nucleic acid amplification testing (NAAT) can be used to confirm the diagnosis in specimens other than blood.
        </p>
        <p>
         Cultures should be obtained of blood and CSF in all infants with suspected disseminated infection. For neonates with signs and symptoms of arthritis, synovial fluid should be aspirated from an affected joint for testing with NAAT, Gram stain and culture. For neonates with scalp abscess, a specimen should be collected from the site and tested with NAAT and culture (in addition to performing blood and CSF cultures). Additional specimens obtained from the conjunctiva, vagina, oropharynx, and rectum are useful for identifying the primary site(s) of infection. A positive NAAT or Gram stain of exudate, CSF, or joint aspirate provides a presumptive basis for initiating treatment [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disseminated infection is treated with
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         or an alternative extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available] or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ]. The duration of treatment is seven days for septicemia, arthritis, or scalp abscess and 10 to 14 days for meningitis [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         As previously discussed,
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         should
         <strong>
          not
         </strong>
         be used in the following settings [
         <a href="#rid18">
          18,19
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants with clinically significant hyperbilirubinemia (since it displaces bilirubin from albumin and may increase the risk of neurotoxicity)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preterm neonates (due to increased risk of hyperbilirubinemia neurotoxicity)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants receiving calcium-containing intravenous fluids including parenteral nutrition (due to risk of precipitation)
        </p>
        <p>
        </p>
        <p>
         Alternative agents that can be used in these circumstances include
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         (if available) or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         .
        </p>
        <p>
         Other classes of antibiotics (eg, macrolides, fluoroquinolones) should
         <strong>
          not
         </strong>
         be used to treat
         <em>
          N. gonorrhoeae
         </em>
         infections, because of high resistance rates.
         <em>
          N. gonorrhoeae
         </em>
         drug resistance is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/15892.html" rel="external">
          "Treatment of uncomplicated gonorrhea (
          <i>
           Neisseria gonorrhoeae
          </i>
          infection) in adults and adolescents", section on 'Antibiotic resistance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H496927567">
         <span class="h1">
          ASYMPTOMATIC INFANTS OF UNTREATED MOTHERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asymptomatic infants whose mothers have untreated gonococcal infection are at high risk for acquiring infection. These infants also should receive systemic treatment with a single dose of
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         or an alternative extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available], or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) using the same dose as for conjunctivitis [
         <a href="#rid1">
          1,2
         </a>
         ]. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
         In addition, the neonate should be evaluated for chlamydial infection [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4993.html" rel="external">
          "Chlamydia trachomatis infections in the newborn", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transmission
         </strong>
         – Newborns acquire gonococcal infection during delivery. The perinatal transmission rate is approximately 30 to 40 percent in women with cervical infection. (See
         <a class="local">
          'Perinatal transmission'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ophthalmia neonatorum
         </strong>
         – In the newborn, the eye is the most frequent site of gonococcal infection (see
         <a class="local">
          'Ophthalmia neonatorum'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gonococcal ophthalmia neonatorum is characterized by a purulent conjunctivitis with profuse exudate and swelling of the eyelids. Without treatment, the infection can extend from the superficial epithelial layers into the subconjunctival connective tissue and the cornea, leading to ulceration, scarring, and visual impairment. The diagnosis is confirmed by nucleic acid amplification testing (NAAT) and/or culture of the exudate. (See
         <a class="local">
          'Clinical features'
         </a>
         above and
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The incidence of gonococcal ophthalmia neonatorum has decreased with the use of routine antibiotic prophylaxis and maternal screening for sexually transmitted infections. (See
         <a class="local">
          'Prevention'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For neonates with gonococcal conjunctivitis, we suggest treatment with a single dose of
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         rather than topical therapy (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Ceftriaxone can be administered intravenously (IV) or intramuscularly (IM) at a dose of 25 to 50 mg/kg (maximum dose 250 mg). Ceftriaxone should
         <strong>
          not
         </strong>
         be used in preterm neonates, infants with clinically significant hyperbilirubinemia, and neonates receiving calcium-containing IV fluids. Alternative agents that can be used in these circumstances include
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         (where available) or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         . Infants receiving treatment for gonococcal conjunctivitis should be hospitalized and observed for response to therapy and for disseminated disease. Infants with confirmed gonococcal disease should also be evaluated for coinfection with
         <em>
          Chlamydia trachomatis
         </em>
         . (See
         <a class="local">
          'Treatment'
         </a>
         above and
         <a class="local">
          'Additional evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other localized infections
         </strong>
         – Localized infection of other mucosal surfaces can occur, including the pharynx, vagina, urethra, and anus. For treatment of these infections in the absence of signs of disseminated disease, we suggest a single dose of
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         or an alternative extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available] or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). The exception is newborns with gonococcal scalp abscess, who should undergo additional evaluation and receive treatment for disseminated infection. (See
         <a class="local">
          'Other localized infection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Disseminated infection
         </strong>
         – Disseminated infection may present as sepsis, arthritis, or meningitis (see
         <a class="local">
          'Disseminated infection and scalp abscess'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Septic arthritis is the most common manifestation of disseminated infection. Gonococcal bacteremia and/or meningitis are rare in the newborn but can be a complication of ophthalmia neonatorum and other localized infections, particularly scalp abscesses. (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For neonates with disseminated infection, we suggest treatment with
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         or an alternative extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available] or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) rather than other agents (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). The duration of treatment is seven days for septicemia, arthritis, or scalp abscess and 10 to 14 days for meningitis. (See
         <a class="local">
          'Other localized infection'
         </a>
         above and
         <a class="local">
          'Disseminated infection and scalp abscess'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Asymptomatic infants
         </strong>
         – For asymptomatic infants whose mothers have untreated gonococcal infection, we suggest treatment with a single dose of an extended-spectrum cephalosporin (eg,
         <a class="drug drug_pediatric" data-topicid="13136" href="/z/d/drug information/13136.html" rel="external">
          ceftriaxone
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13129" href="/z/d/drug information/13129.html" rel="external">
          cefotaxime
         </a>
         [if available], or
         <a class="drug drug_pediatric" data-topicid="13134" href="/z/d/drug information/13134.html" rel="external">
          ceftazidime
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Asymptomatic infants of untreated mothers'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          American Academy of Pediatrics. Gonococcal infections. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd Ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desenclos JC, Garrity D, Scaggs M, Wroten JE. Gonococcal infection of the newborn in Florida, 1984-1989. Sex Transm Dis 1992; 19:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alexander ER. Gonorrhea in the newborn. Ann N Y Acad Sci 1988; 549:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott B, Brunham RC, Laga M, et al. Maternal gonococcal infection as a preventable risk factor for low birth weight. J Infect Dis 1990; 161:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amstey MS, Steadman KT. Asymptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976; 3:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Israel KS, Rissing KB, Brooks GF. Neonatal and childhood gonococcal infections. Clin Obstet Gynecol 1975; 18:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donders GG, Desmyter J, De Wet DH, Van Assche FA. The association of gonorrhoea and syphilis with premature birth and low birthweight. Genitourin Med 1993; 69:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards LE, Barrada MI, Hamann AA, Hakanson EY. Gonorrhea in pregnancy. Am J Obstet Gynecol 1978; 132:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Charles AG, Cohen S, Kass MB, Richman R. Asymptomatic gonorrhea in prenatal patients. Am J Obstet Gynecol 1970; 108:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Handsfield HH, Hodson WA, Holmes KK. Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoea. JAMA 1973; 225:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gao R, Liu B, Yang W, et al. Association of Maternal Sexually Transmitted Infections With Risk of Preterm Birth in the United States. JAMA Netw Open 2021; 4:e2133413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heumann CL, Quilter LA, Eastment MC, et al. Adverse Birth Outcomes and Maternal Neisseria gonorrhoeae Infection: A Population-Based Cohort Study in Washington State. Sex Transm Dis 2017; 44:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kreisel K, Weston E, Braxton J, et al. Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010-2015. Sex Transm Dis 2017; 44:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Di Bartolomeo S, Mirta DH, Janer M, et al. Incidence of Chlamydia trachomatis and other potential pathogens in neonatal conjunctivitis. Int J Infect Dis 2001; 5:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nsanze H, Dawodu A, Usmani A, et al. Ophthalmia neonatorum in the United Arab Emirates. Ann Trop Paediatr 1996; 16:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey KK, Bhat BV, Kanungo R, et al. Clinico-bacteriological study of neonatal conjunctivitis. Indian J Pediatr 1990; 57:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradley JS, Wassel RT, Lee L, Nambiar S. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 2009; 123:e609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donnelly PC, Sutich RM, Easton R, et al. Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature. Paediatr Drugs 2017; 19:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laga M, Meheus A, Piot P. Epidemiology and control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989; 67:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guirguis-Blake JM, Evans CV, Rushkin M. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2019; 321:404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Curry SJ, Krist AH, et al. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA 2019; 321:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darville T. Gonorrhea. Pediatr Rev 1999; 20:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varady E, Nsanze H, Slattery T. Gonococcal scalp abscess in a neonate delivered by caesarean section. Sex Transm Infect 1998; 74:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooperman MB. Gonococcus arthritis in infancy: a clinical study of 44 cases. Am J Dis Child 1927; 33:932.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kohen DP. Neonatal gonococcal arthritis: three cases and review of the literature. Pediatrics 1974; 53:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babl FE, Ram S, Barnett ED, et al. Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis. Pediatr Infect Dis J 2000; 19:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erdem G, Schleiss MR. Gonococcal bacteremia in a neonate. Clin Pediatr (Phila) 2000; 39:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asnis DS, Brennessel DJ. Gonococcal scalp abscess: a risk of intrauterine monitoring. Clin Pediatr (Phila) 1992; 31:316.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4983 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : American Academy of Pediatrics. Gonococcal infections. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd Ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Sexually Transmitted Infections Treatment Guidelines, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1595011" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Gonococcal infection of the newborn in Florida, 1984-1989.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3147611" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Gonorrhea in the newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2313131" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Maternal gonococcal infection as a preventable risk factor for low birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1010761" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Asymptomatic gonorrhea and pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1091381" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Neonatal and childhood gonococcal infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8509101" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The association of gonorrhoea and syphilis with premature birth and low birthweight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/717469" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Gonorrhea in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5505990" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Asymptomatic gonorrhea in prenatal patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4198114" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Neonatal gonococcal infection. I. Orogastric contamination with Neisseria gonorrhoea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34842927" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Association of Maternal Sexually Transmitted Infections With Risk of Preterm Birth in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28407641" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Adverse Birth Outcomes and Maternal Neisseria gonorrhoeae Infection: A Population-Based Cohort Study in Washington State.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28499285" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11724670" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Incidence of Chlamydia trachomatis and other potential pathogens in neonatal conjunctivitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8787362" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Ophthalmia neonatorum in the United Arab Emirates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2286405" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Clinico-bacteriological study of neonatal conjunctivitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19289450" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27718120" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2611972" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Epidemiology and control of gonococcal ophthalmia neonatorum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30694309" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30694327" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10208085" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Gonorrhea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10195058" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Gonococcal scalp abscess in a neonate delivered by caesarean section.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Gonococcus arthritis in infancy: a clinical study of 44 cases
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4205582" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Neonatal gonococcal arthritis: three cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10783027" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10660818" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Gonococcal bacteremia in a neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1582102" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Gonococcal scalp abscess: a risk of intrauterine monitoring.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
